Neutrophil role in in vivo anti-lymphoma activity of rituximab: FCGR3B-NA1/NA2 polymorphism does not influence response and survival after rituximab treatment.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples